Be the first to like this
Complete Report is available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-greece.html .
In 2012, Greece’s population was estimated at 11.4 million. The growth rate of the Greek population is decreasing steadily and this may be due to a negative balance between the mortality and birth rates, and low net rate of immigration. Greek policymakers are now presented with the problems of cost containment due to debt crisis, in addition to having a declining population of the working age group and an increasing elderly population. Greece’s pharmaceutical market was estimated to be worth $7.8 billion in 2012 and is expected to reach approximately $8.23 billion by 2020. The market in grew nominally at a Compound Annual Growth Rate (CAGR) of 0.6% from 2007 to 2012. The medical device market was worth approximately $970 million in 2012 and is expected to reach approximately $1.2 billion by 2020 at a projected CAGR of 3.7%. These positive trends can primarily be attributed to -
• An increasing elderly population
• Increasing awareness regarding early disease detection and diagnosis